.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Navigating The Evolving Landscape of Adalimumab Biosimilars for Inflammatory Disease

Different clinical specialists in the management of inflammatory diseases discuss the role of adalimumab biosimilars in the treatment of their patients.

EP. 1: The Role of Health Care Providers on Encouraging Adalimumab Biosimilar Use

May 3rd 2024

Healthcare providers in inflammatory diseases talk about the role they have on encouraging adalimumab biosimilar use in clinical practice.

EP. 2: Copay Assistance Programs for Adalimumab Biosimilars

May 3rd 2024

Clinicians and a pharmacist discuss how they are managing access and assistance with copay assistance program in their practices.

EP. 3: Common Questions From Patients About Adalimumab Biosimilars

May 10th 2024

Drs Lio, Botsoglou, and Alexrad discuss the most asked questions and common concerns patients have on adalimumab biosimilars.

EP. 4: The Role of Nurses and Support Personal in Educating Patient on Adalimumab Biosimilars

May 10th 2024

Providers in inflammatory diseases discuss the instrumental role nurses and support staff play in educating patients on adalimumab biosimilars.

EP. 5: Resources for Patients and Providers on Adalimumab Biosimilars

May 10th 2024

Expert providers in inflammatory diseases provide additional resources on biosimilars and adalimumab biosimilar for patients and providers.